Nasus Pharma Ltd. (NSRX) is a publicly traded the market company. As of July 28, 2026, NSRX trades at $3.02 with a market cap of $34.08M and a P/E ratio of 0.00. NSRX moved -3.01% today. Year to date, NSRX is -58.76%; over the trailing twelve months it is flat. Its 52-week range spans $1.98 to $9.99. Rallies surfaces NSRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nasus Pharma Ltd. (NSRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NSRX moved -3.01% today.
| Metric | Value |
|---|---|
| Price | $3.02 |
| Market Cap | $34.08M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.99 |
| 52-Week Low | $1.98 |
| Volume | 550 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
NSRX analyst coverage data. Average price target: $0.00.